Loading asset research
Q3 2026 earnings · Nov 9
Jasper Therapeutics Inc. Common Stock
JSPRNasdaq · USD · StocksQuote as of · Exchange session not verified$0.6038
+6.49%
Today
JSPR
Loading 1D prices…
Market cap
$20.4M
Volume
634.2K
52w high
$2.6952w low
$0.315Company profile
Jasper Therapeutics Inc. Common Stock
Jasper Therapeutics, Inc., a clinical stage biotechnology company, focuses on the design and development of therapies to treat immune-mediated diseases. It is advancing a pipeline of medicines, including KP-104, a dual-complement inhibitor that has demonstrated positive outcomes in paroxysmal nocturnal hemoglobinuria (PNH) and is under evaluation in other unmet need nephrology disorders; Briquilimab is an anti-KIT antibody, which has demonstrated clinical results as a conditioning agent for stem cell transplant and mast cell mediated diseases, such as chronic urticarias and allergic asthma; and KP-701, a novel, dual-acting anti-CD79BxCD32B monoclonal antibody (mAb) for autoantibody-mediated disorders. The company is based in Redwood City, California.
Sector
Health Care
Industry
Biological Products, (No Diagnostic Substances)
Exchange
Nasdaq
Display currency
USD
Location
REDWOOD CITY, CA, United States
Employees
22
Fiscal year end
1231
CIK
1788028
Session & valuation
Open$0.592
Previous close$0.567
Day high$0.592
Day low$0.544
30-day avg. volume536.4K
Outstanding shares33.3M
Diluted EPS-$3.95
Latest annual period
P/E (trailing)-0.15
P/E (forward)-0.24
Price / book12.25
Beta—
Dividend yield—
Deterministic peer set
Companies with SEC SIC 2836
Exact regulatory industry matches, ranked by nearest market capitalization.
| Company | Market cap | Revenue | Net margin | Diluted EPS | Today | Consensus |
|---|---|---|---|---|---|---|
| ESLAEstrella Immunopharma Inc. Common Stock | $20.3M | $0.00 | — | -$0.35 | -0.21% | Unrated |
| TCRXTScan Therapeutics Inc. Common Stock | $22M | $10.3M | -1256.81% | -$1.00 | -6.59% | Hold |
| DYAIDyadic International Inc. Common Stock | $16.9M | $3.1M | -238.31% | -$0.23 | +7.32% | Buy |
| BCDABioCardia Inc. Common Stock | $16.3M | $0.00 | — | -$1.23 | +1.90% | Buy |
| PASGPassage Bio Inc. Common Stock | $15.4M | $0.00 | — | -$14.35 | -4.00% | Hold |